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ChildrenAbstract Background: More patients survive the operations for univentricular repair and the
duration of follow up increases, the physicians are becoming increasingly aware of the late failure
and the late complications of the surgery.
Objective: To evaluate the overall outcome of studied patients and to assess their functional status,
and the occurrence of complications.
Patients and methods: This is a retrospective study; patients who underwent univentricular repair
operations either Glenn or Fontan were included in the study. The following data were collected:
age, sex, type of the operation, and presence of early post operative complications. The outcome
was assessed by evaluating clinical status and growth of the patients during the follow-up visits.
Medical and surgical complications were retrieved.
Results: Thirty-nine patients who underwent univentricular repair operations either Glenn or
Fontan were included from the pediatric post operative cardiac outpatient clinic. Their age ranged
from 2–18 years. 38 patients (97.4%) underwent Glenn operation followed by Fontan in 11 (27%)
patients, 1 (2.6%) patient underwent Fontan without any previous operation and 4 (10.2%) patients
underwent multistage palliation (prior operation to Glenn). 8 (20.5%) patients had early complica-
tions in the form of arrhythmia, bleeding, convulsions, and infection. The general functional status
of patients is good; growth curves are within the normal range in 30 (76.9%), and NYHA class I in
24 (61.5%) patients. No late complications during follow-up and no mortality were documented.
Conclusion: Adequate post operative follow up is essential to improve midterm outcome of the
patients.
ª 2013 Production and hosting by Elsevier B.V. on behalf of The Egyptian Pediatric Association.Introduction
The surgical management of single ventricle physiology has
been evolving for decades since the ﬁrst Glenn operation1 in
which the superior vena cava is connected to the right pulmon-
ary artery to carry the blood to the lung for oxygenation.
Glenn operation is habitually part of the staging that results
in a very victorious palliation total arteriopulmonary shunt
by Fontan and Baude.,2 Glenn fell out of favor after Fontan
Table 1 Diagnosis of studied patients.
Diagnosis Number
DORV (double outlet right ventricle) 11 (28.3%)
DILV (double inlet left ventricle) 10 (25.6%)
Tricuspid atresia 9 (23.2%)
Transposition of great vessels 3 (7.7%)
Tetralogy of fallout 2 (5.1%)
Single ventricle 2 (5.1%)
Pulmonary atresia 1 (2.5%)
Complete atrioventricular canal 1 (2.5%)
Table 2 Incidence of complications in studied patients.
Type of complication Incidence
Convulsions 3(7.7%)
Infection 2(5.1%)
Deep venous thrombosis 1(2.6%)
Intracranial hemorrhage 1(2.6%)
Nodal rhythm 1(2.6%)
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looked at again when the early versions of Fontan did not
convey the expected results, the bidirectional Glenn shunt is
now preferred in very small babies <2 years,1 and the Fontan
operation has become the most common procedure performed
for congenital heart disease after the age of 2 years.3 Advances
in operative technique and the adequate post operative follow
up have been accompanied by improvement in early survival
of the patients from 75% to 83% in 1970s to over 90% in
the current era.4 Operative mortality has decreased despite
the application of the operations in patients previously consid-
ered to be high risk either due to complex forms of single
ventricle or inadequate hemodynamics.3 As more patients sur-
vive the operations and the duration of follow up increases, the
physicians are becoming increasingly aware of the late failure
and the late complications of the operation. The aim of this
study is to evaluate the overall outcome of our patients with
single ventricle physiology who underwent univentricular
repair operations (Glenn or Fontan) as regards their functional
status, quality of life, and the occurrence of complications.
Patients and methods
Patients
We reviewed the medical records of the outpatients from the
Pediatric Postoperative Cardiac Outpatient Clinic (PPCOC)
in Cairo University Children’s Hospital from the start of the
clinic in June 2007 till December 2012, we included 39 patients
with single ventricle physiology who underwent univentricular
repair operations either Glenn or Fontan taking into consider-
ation any palliative operation done before, such as shunt or
pulmonary artery banding. A preoperative detailed echocar-
diographic evaluation was done for all patients by machine
vivid 7 probe 3S, 5S, in addition to performing cardiac
catheterization in patients prepared for Fontan operation to
assess the existence of adequate anatomic and physiologic
parameters permitting Fontan completion. These parameters
included low pulmonary vascular resistance, satisfactory ven-
tricular function, good or correctible cardiac valve function,
and unobstructed or reconstructible adequate sized pulmonary
arteries. The ﬁnal anatomic diagnosis was based on results of
two-dimensional echocardiography, cardioangiography, and
operative ﬁndings. During the follow up in the clinic all
patients underwent a complete evaluation in which operative,
perioperative variables, and follow-up clinical data are
recorded. Echocardiographic assessment is done to all patients
on regular follow up periods varying from 6 months to 1 year
according to the condition of the patient.
Methods
We manually reviewed the pre-completed ﬁles to collect the
following data: age, sex, type of the congenital heart disease,
type of the operation, age at the ﬁrst operation, duration of
the hospital stay post operatively, duration of follow up in
the Pediatric Postoperative Cardiac Outpatient Clinic
(PPCOC), presence of early complications in post operative
cardiac intensive care unit, we also included the clinical status
of the patients as regards the NYHA grade in the last visit,
adequate growth by measuring the weight and the height onthe follow up visits, occurrence of complications during period
of follow up in the clinic, the treatment prescribed to the
patients either diuretics, ACE inhibitors, digoxin, pulmonary
vasodilators (sildenaﬁl), anticoagulants as marivan or
antiplatelets as aspocid 5 mg/kg.
Results
The total number of patients in PPCOC was 1002 patients. 39
patients who underwent univentricular repair operations either
Glenn or Fontan were included in the study and represented
3.9%. Their age ranged from 2–18 years and their age at the
ﬁrst operation ranged from 1–12 years. The majority 26
(66.7%) were males. Diagnosis of the studied patients is shown
in Table 1.
22 (56.4%) patients had single left ventricle morphology,
abnormal related vessels in 16 (41%) patients, and pulmonary
stenosis in 21(53.8%) patients.
38 (97.4%) patients had Glenn operation followed by Fon-
tan in 11 (28.2%) patients, 1 (2.6%) patient had done Fontan
operation solely, he was 11 years old male, with the diagnosis
of double outlet right ventricle, D-transposition of great ves-
sels, pulmonary stenosis and 4 (10.2%) patients had multistage
palliation (prior operation to Glenn) in the form of pulmonary
artery banding and shunt. The duration of post operative hos-
pital stay ranged from 4–120 days.
Eight (20.5%) patients had early complications in the form
of arrhythmia, bleeding, convulsions, and infection. Incidence
of complications in studied patients is represented in Table 2.
The follow-up period of the studied patients extended from
6 months to 6 years. The general functional status of patients is
good as evidenced by: growth curves within the normal range
in 30 (76.9%) patients, 8 (20.5%) patients had no heart failure,
and 24 (61.5%) patients are in NYHA class I in the last visit.
No late complications during follow-up and no mortality were
documented. Anticoagulants in the form of oral warfarin was
given to 21 (53.8%) patients followed by antiplatelets therapy
in the form of aspocid 5 mg/kg while 18 (46.1%) patients were
16 L.A. Ibrahimgiven aspocid 5 mg/kg without preceding warfarin. 22 (56.4%)
patients were receiving diuretics, 9 (23%) patients on ACE
inhibitors, 5 (12.8%) patients were on sildenaﬁl, and 1
(2.6%) patient on phenytoin post epileptic status secondary
to early post operative intracranial hemorrhage.
Discussion
The palliation of patients with single ventricle physiology has
been introduced since years by Glenn and Fontan,1 over years
the indications for such operations are broadened to involve
more patients considered to be high risk e.g. Heterotaxy syn-
dromes, especially after a lot of modiﬁcations introduced to
the original operations e.g. lateral tunnel or extra cardiac con-
duit to Fontan operation.5
In our study the number of surviving patients with single
ventricle physiology who underwent surgical palliation is 39
patients with only 12 patients done with Fontan operation, this
is a small number in relation to other studies,5 they report 58
patients post Fontan probably due to longer duration of their
study, late introduction of these operations in developing
countries like Egypt, or due to early postoperative death of
patients which is not included in our study.
The majority of our cases (66.7%) were males, (56.4%) of
patients had single left ventricle morphology, this is similar
to the previous study5 as they report more males and
(60.4%) of their patients were with single left ventricle
morphology. The most common diagnosis of our patients
was double outlet right ventricle in (28.2%) of patients in
contrast to their commonest diagnosis which was tricuspid
atresia (29.3%).
In our study the incidence of early post operative complica-
tions was (20.5%), the most common complication was con-
vulsions which occurred in 3 (7.6%) patients, left thalamic
infarction was diagnosed in one patient after CT and MRI,
prolonged INR and hypoxia were the other causes. The second
most common complication was infection which occurred in 3
(7.6%) patients in the form of pneumonia and wound infec-
tion, this was in contrast to other study6 in which the infection
was the most common complication which occurred in 59%
patients, followed by arrhythmia and then neurological com-
plications. In our study early post operative arrhythmia in
the form of nodal rhythm was diagnosed in 1 patient (2.6%)
this lower incidence was reported than by earlier studies 6%,
30%,7 and similar to the recent study8 but they reported supra-
ventricular tachycardia (SVT), no late arrhythmias were docu-
mented in our patients probably due to short duration of
follow up as incidence of hemodynamic instability and late
arrhythmias increase in young or middle adulthood.3
In our study the patients are in good functional state as
most of the patients (76.9%) had normal growth, 8 (20.5%)
patients had no heart failure, and 22 (56.4%) patients are in
NYHA class I, this is consistent with others5 as 82% of their
patients are in NYHA class I.
Exact regimen for anticoagulation after univentricular re-
pair is unknown,9,10 but higher incidence of thromboembolism
is reported if anticoagulation is not given at all,11 in our policy
we use warfarin for 6 months post operative aiming at keeping
INR between (1.5–2) and due to bad compliance of the pa-
tients and the difﬁculty in repeated assessment of INR, we shift
to aspocid 5 mg/kg for lifelong, we also have 18 patients whostarted on aspocid directly without preceding warfarin, this
was suggested by the previous study,12 with good midterm re-
sults as we have no thromboembolic complications in these 18
patients.
Due to the palliative nature of Fontan operation the pa-
tients are in need of cardio protective drugs, in our study 22
(56.4%) patients are receiving diuretics, 9 (23%) patients on
ACE inhibitors, this was different from other studies which
suggest the use of after load reduction in these patients as it
contributes to improved long term outcome in the patients,13,14
probably we need long time for follow up to assess this issue.
We have 0% mortality in our patients during the period of
follow up (6 years), this is consistent with other studies,5,8 this
may be attributed to proper selection of the patients, multi-
stage palliation, proper follow up, anticipation of common
complication after the procedures.
This study has limitations including a small number of the
patients, short period of follow up as these operations are
recently applied in our center, and functional status of the
patients is better assessed by the use of exercise test (5 min
walking test).
Conclusion
In our center, univentricular repair procedures were intro-
duced recently, midterm outcome of the patients is promising
evidenced by good functional status of the patients, low inci-
dence of complications and no mortality, this is probably
due to appropriate selection of patients including optimal
hemodynamics, multistage palliation, and adequate post oper-
ative follow up. Our policy of anticoagulation is effective in
preventing thromboembolic complications, but it is limited
by short duration of follow up, and relatively small number
of patients.
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